Browse Items (92 total)

• Building a National Capability to Monitor and Assess Medical Countermeasure Use During a Public Health Emergency: Going Beyond the Last Mile: Proceedings of a Workshop

  Tags Ethics, Federal Research Partners, Informed Consent, Institutional Review Board (IRB), Patient Care, Prophylaxis, Public Health, R-Res&Pub, Therapeutics, Vaccine Study
  Creator: National Academies of Sciences, E. and Medicine
  Subject: Research
  Item Type: Publication
  Date Last Updated: 2017-10-31
  Description: During public health emergencies (PHEs) involving chemical, biological, radiological, or nuclear threats or emerging infectious diseases, medical countermeasures (MCMs) (e.g., drugs, vaccines, devices) may need to be dispensed or administered to…
• 

  Preparing for Serious Communicable Diseases in the United States: What the Ebola Virus Epidemic Has Taught Us

  Tags Antibodies, Contact Transmission, Critical Care, Droplet Transmission, Ebola, Epidemic, Infection Prevention and Control, Outbreaks, Patient Care, Personal Protective Equipment (PPE), Prophylaxis, Public Health, R-PPE, R-Res&Pub, Therapeutics, Vaccine Study, Viral Hemorrhagic Fever
  Creator: Varkey, J. B. and B. S. Ribner
  Subject: General
  Item Type: Publication
  Date Last Updated: 2016-06-01
  Description: Ending the West Africa Ebola virus disease (EVD) outbreak required an unprecedented international response.
• 

  Prioritizing diseases for research and development in emergency contexts

  Tags Coronavirus, Crimean Congo Haemorrhagic Fever (CCHF), Ebola, Epidemic, Experimental Drugs, Lassa, Marburg, Medical Surveillance, MERS-CoV, Mpox, Orthopox Virus, Outbreaks, Pandemic, Plague, Prophylaxis, Public Health, R-Gen, Respiratory Pathogen, SARS, Special Pathogens, Therapeutics, Vaccine Study, Variola, Viral Hemorrhagic Fever
  Creator: World Health Organization
  Subject: General
  Item Type: Guide
  Date Last Updated: 2022
  Description: Worldwide, the number of potential pathogens is very large, while the resources for disease research and development (R&D) is limited. To ensure efforts under WHO’s R&D Blueprint are focused and productive, a list of diseases and pathogens are…

• Threading the NEIDL (National Emerging Infectious Diseases Laboratories)

  Tags Basic Science Research, Biosafety, Ebola, Lab, Laboratory, R-Res&Pub, Therapeutics, Vaccine Study, Viral Hemorrhagic Fever
  Creator: American Society for Microbiology
  Subject: Research
  Item Type: Video
  Date Last Updated: 2018-01-02
  Description: This video explores the National Emerging Infectious Diseases Laboratories (NEIDL) security, a Biological Safety Level (BSL)-4 safety suit, and the facility.
• 

  Antibodies Against Ebola and Lassa

  Tags Antibodies, Ebola, Immunology, Lassa, R-Res&Pub, Vaccine Study, Viral Hemorrhagic Fever, Virology
  Creator: NIH
  Subject: Research
  Item Type: Video
  Date Last Updated: 2017-12-05
  Description: The 2017 Kinyoun Lecture discusses antibodies protecting against Ebola and Lassa, and the need for research collaboration.

• Completing the Development of Ebola Vaccines: CURRENT STATUS, REMAINING CHALLENGES, AND RECOMMENDATIONS

  Tags Clinical Trial, Ebola, Ethics, Federal Research Partners, Prophylaxis, Public Health, R-Res&Pub, R-T&C, Research Design, Vaccine Study
  Creator: University of Minnesota, Center for Infectious Disease Research and Policy
  Subject: Treatment & Care
  Item Type: Publication
  Date Last Updated: 2017-01-17
  Description: In the third major report from the Wellcome Trust–CIDRAP Ebola Vaccine Team B reflects on progress to date and the remaining challenges faced.
• 

  CC Grand Rounds: Response to an Outbreak: Ebola Virus Monoclonal Antibody (mAb114) Rapid Clinical Development
  

  Tags Antibodies, Ebola, Immunology, Prophylaxis, R-Res&Pub, Research, Therapeutics, Vaccine Study
  Creator: NIH
  Subject: Research
  Item Type: Video
  Date Last Updated: 2019-03-19
  Description: This is a one hour lecture about the monoclonal antibody (mAb114) and ebola. It requires Flash plugin.

• Researching Ebola in Africa: The Partnership for Research on Ebola Virus in Liberia (PREVAIL)

  Tags Clinical Trial, Ebola, Prophylaxis, R-Res&Pub, Research, Survivors, Therapeutics, Vaccine Study, Viral Hemorrhagic Fever
  Creator: National Institute of Allergy and Infectious Diseases [National Institutes of Health] NIH (NIAID)
  Subject: Research
  Item Type: Publication
  Date Last Updated: 2019-01-04
  Description: The 2014-2016 Ebola outbreak in West Africa was the largest in history, with nearly 28,700 cases and more than 11,300 deaths. As local and international healthcare workers responded to the outbreak, the U.S. National Institute of Allergy and…

• Ebola Recommendations for Organizations

  Tags Clinical Trial, Ebola, Outbreaks, Personal Protective Equipment (PPE), R-PM, R-PPE, Travel Screening, Vaccine Study
  Creator: CDC
  Subject: Personnel Management
  Item Type: Guide
  Date Last Updated: 2019-04-16
  Description: Recommendations for organizations sending US-based health care or emergency response workers to areas with Ebola outbreaks and predeparture assessment of any workers traveling from Ebola outbreak areas to the United States.

• Preliminary results on the efficacy of rVSV-ZEBOV-GP Ebola vaccine using the ring vaccination strategy in the control of an Ebola outbreak in the Democratic Republic of the Congo: an example of integration of research into epidemic response.

  Tags Clinical Trial, Ebola, Epidemic, Outbreaks, R-Res&Pub, R-T&C, Research, Research Design, Therapeutics, Vaccine Study
  Creator: WHO
  Subject: Infection Control
  Item Type: Publication
  Date Last Updated: 2019-04-12
  Description: ABOUT THIS ANALYSIS: DRC’s national research institute, the Institut National pour la Recherche Biomedicale (INRB) and WHO have conducted a preliminary analysis of the data being collected from the ring vaccination protocol. The analysis summarized…